Roundup
+3
Jun 7, 2026
•
10 min read
The food industry considers GLP-1s
Lawmakers are mixed on how much tax payers should foot the bill for healthy foods, while food manufacturers are revising their strategies for the weight-loss drug era.
Roundup
+5
May 30, 2026
•
10 min read
AI drug discovery’s expensive reality
Rising compute costs have biotech firms rethinking how they use large language models.
